We serve Chemical Name:2,3,5-Trifluoropyridine CAS:76469-41-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2,3,5-Trifluoropyridine
CAS.NO:76469-41-5
Synonyms:2,3,5-trifluoro-pyridine;2,3,5-Trifluoropyridine;Pyridine, 2,3,5-trifluoro-;MFCD03001162
Molecular Formula:C5H2F3N
Molecular Weight:133.071
HS Code:2933399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:96.7±35.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.424
PSA:12.89000
Exact Mass:133.013931
LogP:0.94
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:1993
Packing Group:III
Contact us for information like 2,3,5-trifluoro-pyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD03001162 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD03001162 Use and application,2,3,5-Trifluoropyridine technical grade,usp/ep/jp grade.
Related News: Government prosecutors often consider whether a corporation made a genuine effort to investigate and address potentially illegal activities once learning of them. 2,3,5-Trifluoropyridine manufacturer Government prosecutors often consider whether a corporation made a genuine effort to investigate and address potentially illegal activities once learning of them. 2,3,5-Trifluoropyridine supplier The two trials studied similar patient populations, Tendler said, but VMP was an old standard of care that’s not really used today in the U.S. Still, Tendler believes the two regimens may both have roles to play based on each patient’s ability to tolerate them. Whichever cocktail physicians choose, the two phase 3 studies have confirmed the benefit of Darzalex in transplant-ineligible patients, he added. 2,3,5-Trifluoropyridine vendor This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines. Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician��s Choice plus Best Supportive Care. 2,3,5-Trifluoropyridine factory The API can be directly formulated, and the intermediate can only be used to synthesize the next product. Only through the intermediate can the API be manufactured.
